Immunome, Inc.

Immunome, Inc.

Biotechnology Research

Exton, PA 6,140 followers

Developing antibody-based therapeutics by unlocking the human memory B cell response.

About us

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Exton, PA
Type
Public Company
Founded
2008
Specialties
immunotherapy, biotechnology, and antigen discovery

Locations

Employees at Immunome, Inc.

Updates

Similar pages

Browse jobs

Funding

Immunome, Inc. 20 total rounds

Last Round

Post IPO equity

US$ 230.0M

See more info on crunchbase